Filter

Refine by collections

  • Pituitary and Hypothalamus (6)

Refine by date

—
  • Print
  • Save

Search Results

You are looking at 1 - 6 of 6 items for :

  • "body mass index (BMI)" x
  • Pituitary and Hypothalamus x
Clear All
Julia Beckhaus Department of Pediatrics and Pediatric Hematology/Oncology, University Children’s Hospital, Carl von Ossietzky Universität, Klinikum Oldenburg AöR, Oldenburg, Germany
Division of Epidemiology and Biometry, Carl von Ossietzky Universität, Oldenburg, Germany

Search for other papers by Julia Beckhaus in
Google Scholar
PubMed Close
,
Maria Eveslage Institute of Biostatistics and Clinical Research, University of Münster, Münster, Germany

Search for other papers by Maria Eveslage in
Google Scholar
PubMed Close
,
Brigitte Bison Diagnostic and Interventional Neuroradiology, Faculty of Medicine, University of Augsburg, Augsburg, Germany

Search for other papers by Brigitte Bison in
Google Scholar
PubMed Close
,
Carsten Friedrich Department of Pediatrics and Pediatric Hematology/Oncology, University Children’s Hospital, Carl von Ossietzky Universität, Klinikum Oldenburg AöR, Oldenburg, Germany

Search for other papers by Carsten Friedrich in
Google Scholar
PubMed Close
, and
Hermann L Müller Department of Pediatrics and Pediatric Hematology/Oncology, University Children’s Hospital, Carl von Ossietzky Universität, Klinikum Oldenburg AöR, Oldenburg, Germany

Search for other papers by Hermann L Müller in
Google Scholar
PubMed Close

in children of the general population ( 11 ). However, in patients with childhood-onset CP, the association of parental body mass index (BMI) and obesity after treatment is not well understood. In our study, body weight, body height, and BMI in

Article Type:
Research Article
Collections:
Pituitary and Hypothalamus
DOI:
https://doi.org/10.1530/EC-24-0126
Volume/Issue:
Volume 13: Issue 8
Open access
Julia Beckhaus Department of Pediatrics and Pediatric Hematology/Oncology, University Children’s Hospital, Carl von Ossietzky University, Klinikum Oldenburg AöR, Oldenburg, Germany
Division of Epidemiology and Biometry, Carl von Ossietzky University, Oldenburg, Germany

Search for other papers by Julia Beckhaus in
Google Scholar
PubMed Close
,
Svenja Boekhoff Department of Pediatrics and Pediatric Hematology/Oncology, University Children’s Hospital, Carl von Ossietzky University, Klinikum Oldenburg AöR, Oldenburg, Germany

Search for other papers by Svenja Boekhoff in
Google Scholar
PubMed Close
,
Katrin Scheinemann Pediatric Hematology-Oncology Center, Children’s Hospital of Eastern Switzerland, St. Gallen, Switzerland
Faculty of Health Sciences and Medicine, University of Lucerne, Lucerne, Switzerland
Department of Pediatrics, McMaster Children’s Hospital and McMaster University, Hamilton, Ontario, Canada

Search for other papers by Katrin Scheinemann in
Google Scholar
PubMed Close
,
Freimut H Schilling Department of Pediatrics, Division of Pediatric Hematology and Oncology, Children’s Hospital Lucerne, Lucerne, Switzerland

Search for other papers by Freimut H Schilling in
Google Scholar
PubMed Close
,
Gudrun Fleischhack Pediatrics III, University Hospital of Essen, Essen, Germany

Search for other papers by Gudrun Fleischhack in
Google Scholar
PubMed Close
,
Gerhard Binder University Children’s Hospital, Pediatric Endocrinology, University Tübingen, Tübingen, Germany

Search for other papers by Gerhard Binder in
Google Scholar
PubMed Close
,
Brigitte Bison Diagnostic and Interventional Neuroradiology, Faculty of Medicine, University of Augsburg, Augsburg, Germany

Search for other papers by Brigitte Bison in
Google Scholar
PubMed Close
,
Torsten Pietsch Institute of Neuropathology, DGNN Brain Tumor Reference Center, University of Bonn Medical Center, Bonn, Germany

Search for other papers by Torsten Pietsch in
Google Scholar
PubMed Close
,
Carsten Friedrich Department of Pediatrics and Pediatric Hematology/Oncology, University Children’s Hospital, Carl von Ossietzky University, Klinikum Oldenburg AöR, Oldenburg, Germany

Search for other papers by Carsten Friedrich in
Google Scholar
PubMed Close
, and
Hermann L Müller Department of Pediatrics and Pediatric Hematology/Oncology, University Children’s Hospital, Carl von Ossietzky University, Klinikum Oldenburg AöR, Oldenburg, Germany

Search for other papers by Hermann L Müller in
Google Scholar
PubMed Close

patients with hypothalamic involvement (HI) and/or treatment-related hypothalamic lesion (HL), the body mass index (BMI) increases during the first year after surgery, frequently resulting in morbid obesity ( 11 , 12 , 13 , 14 , 15 ). Severe obesity

Article Type:
Research Article
Collections:
Pituitary and Hypothalamus
DOI:
https://doi.org/10.1530/EC-23-0294
Volume/Issue:
Volume 12: Issue 12
Open access
Antonella Giampietro Pituitary Unit, Department of Endocrinology, Fondazione A Gemelli, IRCCS, Università Cattolica del Sacro Cuore, Rome, Italy

Search for other papers by Antonella Giampietro in
Google Scholar
PubMed Close
,
Sabrina Chiloiro Pituitary Unit, Department of Endocrinology, Fondazione A Gemelli, IRCCS, Università Cattolica del Sacro Cuore, Rome, Italy

Search for other papers by Sabrina Chiloiro in
Google Scholar
PubMed Close
,
Claudio Urbani Endocrinology II Unit, Department of Medicine, Azienda Ospedaliero Universitaria Pisana, Pisa, Italy

Search for other papers by Claudio Urbani in
Google Scholar
PubMed Close
,
Rosario Pivonello Dipartimento Di Medicina Clinica E Chirurgia, Sezione Di Endocrinologia, Università Federico II di Napoli, Naples, Italy

Search for other papers by Rosario Pivonello in
Google Scholar
PubMed Close
,
Martin Ove Carlsson Global Medical Affairs, Pfizer Rare Disease, Brussels, Belgium

Search for other papers by Martin Ove Carlsson in
Google Scholar
PubMed Close
,
Francesca Dassie Department of Medicine - DIMED, University of Padua, Padua, Italy

Search for other papers by Francesca Dassie in
Google Scholar
PubMed Close
,
Nunzia Prencipe Division of Endocrinology, Diabetology and Metabolism, Department of Medical Science, University of Turin, Turin, Italy

Search for other papers by Nunzia Prencipe in
Google Scholar
PubMed Close
,
Marta Ragonese Unit of Endocrinology, Department of Human Pathology, University of Messina, Messina, Italy

Search for other papers by Marta Ragonese in
Google Scholar
PubMed Close
,
Roy Gomez Global Medical Affairs, Pfizer Rare Disease, Brussels, Belgium

Search for other papers by Roy Gomez in
Google Scholar
PubMed Close
,
Simona Granato Medical Department, Pfizer Italia, Rome, Italy

Search for other papers by Simona Granato in
Google Scholar
PubMed Close
,
Salvatore Cannavò Unit of Endocrinology, Department of Human Pathology, University of Messina, Messina, Italy

Search for other papers by Salvatore Cannavò in
Google Scholar
PubMed Close
,
Silvia Grottoli Division of Endocrinology, Diabetology and Metabolism, Department of Medical Science, University of Turin, Turin, Italy

Search for other papers by Silvia Grottoli in
Google Scholar
PubMed Close
,
Pietro Maffei Department of Medicine - DIMED, University of Padua, Padua, Italy

Search for other papers by Pietro Maffei in
Google Scholar
PubMed Close
,
Annamaria Colao Dipartimento Di Medicina Clinica E Chirurgia, Sezione Di Endocrinologia, Università Federico II di Napoli, Naples, Italy

Search for other papers by Annamaria Colao in
Google Scholar
PubMed Close
,
Fausto Bogazzi Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy

Search for other papers by Fausto Bogazzi in
Google Scholar
PubMed Close
, and
Antonio Bianchi Pituitary Unit, Department of Endocrinology, Fondazione A Gemelli, IRCCS, Università Cattolica del Sacro Cuore, Rome, Italy

Search for other papers by Antonio Bianchi in
Google Scholar
PubMed Close

suggested that pretreatment IGF-1 levels, sex, body mass index (BMI) and previous radiotherapy may play a role in the efficacy/effectiveness of pharmacologic treatments to achieve disease control ( 17 , 18 , 19 , 20 , 21 ). However, results were

Article Type:
Research Article
Collections:
Pituitary and Hypothalamus
DOI:
https://doi.org/10.1530/EC-23-0247
Volume/Issue:
Volume 13: Issue 3
Open access
Sherwin Criseno Institute of Metabolism and Systems Research, University of Birmingham, Birmingham, UK
Centre for Endocrinology, Diabetes and Metabolism, Birmingham Health Partners, Birmingham, UK
Department of Endocrinology, Queen Elizabeth Hospital, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK
School of Nursing and Midwifery, Institute of Clinical Sciences, University of Birmingham, UK

Search for other papers by Sherwin Criseno in
Google Scholar
PubMed Close
,
Helena Gleeson Centre for Endocrinology, Diabetes and Metabolism, Birmingham Health Partners, Birmingham, UK
Department of Endocrinology, Queen Elizabeth Hospital, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK

Search for other papers by Helena Gleeson in
Google Scholar
PubMed Close
,
Andrew A Toogood Department of Endocrinology, Queen Elizabeth Hospital, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK

Search for other papers by Andrew A Toogood in
Google Scholar
PubMed Close
,
Neil Gittoes Institute of Metabolism and Systems Research, University of Birmingham, Birmingham, UK
Centre for Endocrinology, Diabetes and Metabolism, Birmingham Health Partners, Birmingham, UK
Department of Endocrinology, Queen Elizabeth Hospital, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK

Search for other papers by Neil Gittoes in
Google Scholar
PubMed Close
,
Anne Topping School of Nursing and Midwifery, Institute of Clinical Sciences, University of Birmingham, UK

Search for other papers by Anne Topping in
Google Scholar
PubMed Close
, and
Niki Karavitaki Institute of Metabolism and Systems Research, University of Birmingham, Birmingham, UK
Centre for Endocrinology, Diabetes and Metabolism, Birmingham Health Partners, Birmingham, UK
Department of Endocrinology, Queen Elizabeth Hospital, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK

Search for other papers by Niki Karavitaki in
Google Scholar
PubMed Close

longitudinal studies in adults over the age of 25 have shown that long-term treatment with GH does not normalise the metabolic profile and it even increases body mass index (BMI) ( 3 , 11 , 12 ). Currently, GH treatment in adults involves daily subcutaneous

Article Type:
Research Article
Collections:
Pituitary and Hypothalamus
DOI:
https://doi.org/10.1530/EC-23-0533
Volume/Issue:
Volume 13: Issue 5
Open access
I M A A van Roessel Department of Pediatric Neuro-oncology, Princess Máxima Center, Heidelberglaan, CS Utrecht, The Netherlands
Department of Pediatric Endocrinology, Wilhelmina Children’s Hospital, University Medical Center, Lundlaan, EA Utrecht, The Netherlands

Search for other papers by I M A A van Roessel in
Google Scholar
PubMed Close
,
J E Gorter Department of Pediatric Neuro-oncology, Princess Máxima Center, Heidelberglaan, CS Utrecht, The Netherlands
Department of Pediatric Endocrinology, Wilhelmina Children’s Hospital, University Medical Center, Lundlaan, EA Utrecht, The Netherlands

Search for other papers by J E Gorter in
Google Scholar
PubMed Close
,
B Bakker Department of Pediatric Neuro-oncology, Princess Máxima Center, Heidelberglaan, CS Utrecht, The Netherlands
Department of Pediatric Endocrinology, Wilhelmina Children’s Hospital, University Medical Center, Lundlaan, EA Utrecht, The Netherlands

Search for other papers by B Bakker in
Google Scholar
PubMed Close
,
M M van den Heuvel-Eibrink Princess Máxima Center, Heidelberglaan, CS Utrecht, The Netherlands
Wilhelmina Children’s Hospital, University Medical Center, Lundlaan, EA Utrecht, The Netherlands

Search for other papers by M M van den Heuvel-Eibrink in
Google Scholar
PubMed Close
,
M H Lequin Department of Radiology, Princess Máxima Center, Heidelberglaan, CS Utrecht, The Netherlands
Department of Radiology, Wilhelmina Children's Hospital, University Medical Center Utrecht, Utrecht, The Netherlands

Search for other papers by M H Lequin in
Google Scholar
PubMed Close
,
J van der Lugt Department of Pediatric Neuro-oncology, Princess Máxima Center, Heidelberglaan, CS Utrecht, The Netherlands

Search for other papers by J van der Lugt in
Google Scholar
PubMed Close
,
L Meijer Department of Pediatric Neuro-oncology, Princess Máxima Center, Heidelberglaan, CS Utrecht, The Netherlands

Search for other papers by L Meijer in
Google Scholar
PubMed Close
,
A Y N Schouten-van Meeteren Department of Pediatric Neuro-oncology, Princess Máxima Center, Heidelberglaan, CS Utrecht, The Netherlands

Search for other papers by A Y N Schouten-van Meeteren in
Google Scholar
PubMed Close
, and
H M van Santen Department of Pediatric Neuro-oncology, Princess Máxima Center, Heidelberglaan, CS Utrecht, The Netherlands
Department of Pediatric Endocrinology, Wilhelmina Children’s Hospital, University Medical Center, Lundlaan, EA Utrecht, The Netherlands

Search for other papers by H M van Santen in
Google Scholar
PubMed Close

mineralization ( 15 , 16 ). Besides the increase in body mass index (BMI), pituitary deficiencies and immobilization (due to visual problems, fatigue, and/or lack of initiative) are common in these patients and may contribute to bone problems ( 17 ). Lastly

Article Type:
Research Article
Collections:
Pituitary and Hypothalamus
DOI:
https://doi.org/10.1530/EC-24-0224
Volume/Issue:
Volume 13: Issue 10
Open access
Kevin C J Yuen Departments of Neuroendocrinology and Neurosurgery, Barrow Neurological Institute, University of Arizona College of Medicine and Creighton School of Medicine, Phoenix, Arizona, United States

Search for other papers by Kevin C J Yuen in
Google Scholar
PubMed Close
,
Gudmundur Johannsson Department of Endocrinology, Sahlgrenska University Hospital and Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden

Search for other papers by Gudmundur Johannsson in
Google Scholar
PubMed Close
,
Ken K Y Ho The Garvan Institute of Medical Research and the Faculty of Medicine, University of New South Wales, Sydney, Australia

Search for other papers by Ken K Y Ho in
Google Scholar
PubMed Close
,
Bradley S Miller Pediatric Endocrinology, University of Minnesota Medical School, M Health Fairview Masonic Children’s Hospital, Minneapolis, Minnesota, United States

Search for other papers by Bradley S Miller in
Google Scholar
PubMed Close
,
Ignacio Bergada Centro de Investigaciones Endocrinológicas "Dr César Bergadá" (CEDIE), CONICET-FEI-División de Endocrinología, Hospital de Niños Ricardo Gutiérrez, Buenos Aires, Argentina

Search for other papers by Ignacio Bergada in
Google Scholar
PubMed Close
, and
Alan D Rogol Pediatric Diabetes and Endocrinology, University of Virginia, Charlottesville, Virginia, United States

Search for other papers by Alan D Rogol in
Google Scholar
PubMed Close

/obese subjects ( 57 , 58 ). Lowering the GH cut-off from 3 to 1 μg/L has been shown to reduce misclassifying adult GHD in overweight (body mass index (BMI) 25–30 kg/m 2 ) patients with a low pre-test probability and in obese (BMI >30 kg/m 2 ) patients ( 57 , 59

Article Type:
Review Article
Collections:
Pituitary and Hypothalamus
DOI:
https://doi.org/10.1530/EC-22-0504
Volume/Issue:
Volume 12: Issue 7
Open access